0001493152-23-002033.txt : 20230120 0001493152-23-002033.hdr.sgml : 20230120 20230120162413 ACCESSION NUMBER: 0001493152-23-002033 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 EFFECTIVENESS DATE: 20230120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001757499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-471409 FILM NUMBER: 23541337 BUSINESS ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2404034212 MAIL ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0708 D LIVE 0001757499 Shuttle Pharmaceuticals Holdings, Inc. ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD MARYLAND 20850 240-403-4212 DELAWARE Shuttle Pharma Acquisition Corp., Inc. None Corporation true 2018 Anatoly Dritschilo c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Executive Officer Director Chief Executive Officer and Chairman Peter Dritschilo c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Executive Officer President and Chief Operating Officer Mira Jung c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Executive Officer Chief Scientific Officer for Biology Tyvin Rich c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Executive Officer Chief Medical Officer Michael Vander Hoek c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Executive Officer Chief Financial Officer and Vice President - Operations and Regulatory Milton Brown c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Director Steven Richards c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Director Bette Jacobs c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Director Chris Senanayake c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Director Joshua Schafer c/o Shuttle Pharmaceuticals One Research Court, Suite 450 Rockville MD MARYLAND 20850 Director Pharmaceuticals Decline to Disclose 06b false 2023-01-11 false true true Convertible Note and Warrant to Purchase Common Stock false 4000000 Boustead Securities, LLC 141391 None None 6 VENTURE IRVINE CA CALIFORNIA CA NY NEW YORK false 4000000 4000000 0 The issuer sold $4,300,000 in convertible notes and warrants at a purchase price of $4,000,000. false 1 320000 0 Boustead Securities served as placement agent and is entitled to a commission equal to 7.0% cash, 1.0% in non-accountable fees and 7.0% warrants. 0 true false Shuttle Pharmaceuticals Holdings, Inc. /s/ Anatoly Dritschilo Anatoly Dritschilo Chief Executive Officer 2023-01-20